{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:36:50Z","timestamp":1790087810182,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jacl.2021.08.007","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T11:01:51Z","timestamp":1629543711000},"page":"674-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-8979","authenticated-orcid":false,"given":"Trond P.","family":"Leren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Pr\u00f8ven","family":"Bogsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2021.08.007_bib0001","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment","volume":"111","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.08.007_bib0002","series-title":"Familial hypercholesterolemia","first-page":"2863","article-title":"The metabolic basis of inherited disease","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.jacl.2021.08.007_bib0003","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2021.08.007_bib0004","series-title":"Introduction: structure and metabolism of plasma lipoproteins","first-page":"2705","article-title":"The metabolic basis of inherited disease","author":"Havel","year":"2001"},{"key":"10.1016\/j.jacl.2021.08.007_bib0005","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-2275(20)42605-7","article-title":"Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia","volume":"31","author":"Innerarity","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.08.007_bib0006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.2009.02167.x","article-title":"The unique role of proprotein convertase subtilisin\/kexin type 9 in cholesterol homeostasis","volume":"266","author":"Mousavi","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2021.08.007_bib0007","series-title":"Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins","first-page":"2717","article-title":"The metabolic basis of inherited disease","author":"Kane","year":"2001"},{"key":"10.1016\/j.jacl.2021.08.007_bib0008","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.08.007_bib0009","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2021.08.007_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-0004.1976.tb01569.x","article-title":"The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds","volume":"9","author":"Heiberg","year":"1976","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2021.02.022","article-title":"Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020","volume":"322","author":"Leren","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2021.08.007_bib0012","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart disease in familial hyperlipoproteinaemic states","volume":"ii","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2021.08.007_bib0014","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0015","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long-term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2021.08.007_bib0016","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2021.08.007_bib0017","first-page":"26","article-title":"Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening","volume":"11","author":"Leren","year":"2008","journal-title":"Community Genet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0018","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0019","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.163.1.65","article-title":"Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia","volume":"163","author":"Umans-Eckenhausen","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2021.08.007_bib0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MOL.0b013e32830636e5","article-title":"What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia","volume":"19","author":"Humphries","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2021.08.007_bib0021","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00320.x","article-title":"Cascade genetic screening for familial hypercholesterolemia","volume":"66","author":"Leren","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2021.08.007_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4290","article-title":"Screening for hypercholesterolemia versus case finding for familial hypercholesterolemia: systematic review and cost effectiveness analysis","volume":"4","author":"Marks","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jacl.2021.08.007_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosissup.2017.05.019","article-title":"Cascade screening for familial hypercholesterolemia: practical consequences","volume":"30","author":"Louter","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2021.08.007_bib0024","unstructured":"Act relating to the application of biotechnology in medicine, Law no. 56 of 5 August 1994."},{"key":"10.1016\/j.jacl.2021.08.007_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cccn.2005.01.028","article-title":"Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA","volume":"356","author":"Holla","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2021.08.007_bib0026","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2021.08.007_bib0027","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/humu.20256","article-title":"Update of the molecular basis of familial hypercholesterolemia in the Netherlands","volume":"26","author":"Fouchier","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2021.08.007_bib0028","first-page":"2363","article-title":"Lipid profile in children and adolescents with familial hypercholesterolemia","volume":"127","author":"Leren","year":"2007","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.jacl.2021.08.007_bib0029","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jech.55.7.500","article-title":"Results from a family and DNA based active identification programme for familial hypercholesterolaemia","volume":"55","author":"ten Asbroek","year":"2001","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jacl.2021.08.007_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742100146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742100146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:37:15Z","timestamp":1761831435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742100146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S193328742100146X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.08.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}